INDRAPRASTHA MEDICAL CORPORATION
|
INDRAPRASTHA MEDICAL CORPORATION Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 9.40 | 6.39 | 0.25 | 4.76 | 3.10 |
| CEPS(Rs) | 13.68 | 10.21 | 3.89 | 8.36 | 6.35 |
| DPS(Rs) | 3.00 | 2.50 | - | - | 1.60 |
| Book NAV/Share(Rs) | 41.39 | 35.50 | 29.75 | 29.21 | 26.62 |
| Tax Rate(%) | 26.48 | 25.86 | 45.69 | 9.48 | 36.32 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 13.72 | 12.87 | 6.57 | 10.40 | 10.25 |
| EBIT Margin(%) | 11.06 | 9.29 | 1.24 | 6.51 | 6.53 |
| Pre Tax Margin(%) | 10.67 | 8.90 | 0.70 | 5.80 | 5.66 |
| PAT Margin (%) | 7.84 | 6.60 | 0.38 | 5.25 | 3.60 |
| Cash Profit Margin (%) | 11.42 | 10.53 | 5.81 | 9.22 | 7.38 |
| Performance Ratios | |||||
| ROA(%) | 16.94 | 13.12 | 0.53 | 10.01 | 6.65 |
| ROE(%) | 24.44 | 19.60 | 0.86 | 17.05 | 11.93 |
| ROCE(%) | 34.46 | 27.58 | 2.80 | 20.15 | 18.29 |
| Asset Turnover(x) | 2.16 | 1.99 | 1.39 | 1.91 | 1.84 |
| Sales/Fixed Asset(x) | 2.27 | 1.92 | 1.36 | 1.97 | 2.01 |
| Working Capital/Sales(x) | 11.76 | 13.89 | 24.03 | 444.97 | 68.78 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.44 | 0.52 | 0.74 | 0.51 | 0.50 |
| Receivable days | 18.54 | 22.75 | 43.60 | 34.13 | 37.20 |
| Inventory Days | 3.06 | 3.85 | 6.19 | 4.48 | 4.04 |
| Payable days | - | - | - | - | - |
| Valuation Parameters | |||||
| PER(x) | 8.27 | 9.14 | 211.45 | 7.13 | 12.37 |
| PCE(x) | 5.68 | 5.73 | 13.82 | 4.06 | 6.04 |
| Price/Book(x) | 1.88 | 1.65 | 1.81 | 1.16 | 1.44 |
| Yield(%) | 3.86 | 4.28 | - | - | 4.17 |
| EV/Net Sales(x) | 0.53 | 0.53 | 0.76 | 0.35 | 0.44 |
| EV/Core EBITDA(x) | 3.63 | 3.98 | 11.36 | 3.34 | 4.31 |
| EV/EBIT(x) | 4.81 | 5.67 | 60.97 | 5.38 | 6.81 |
| EV/CE(x) | 1.05 | 1.01 | 1.08 | 0.65 | 0.83 |
| M Cap / Sales | 0.65 | 0.60 | 0.80 | 0.37 | 0.45 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 23.70 | 44.80 | -26.17 | 5.40 | 4.72 |
| Core EBITDA Growth(%) | 36.88 | 186.74 | -52.97 | 7.18 | 10.41 |
| EBIT Growth(%) | 47.26 | 981.00 | -85.90 | 5.08 | 20.02 |
| PAT Growth(%) | 46.96 | 2,415.88 | -94.66 | 53.54 | 34.64 |
| EPS Growth(%) | 46.96 | 2,415.62 | -94.66 | 53.54 | 34.64 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | 0.01 | 0.09 |
| Current Ratio(x) | 1.72 | 1.68 | 1.22 | 1.01 | 1.09 |
| Quick Ratio(x) | 1.66 | 1.58 | 1.14 | 0.93 | 1.03 |
| Interest Cover(x) | 28.38 | 24.19 | 2.28 | 9.14 | 7.49 |
| Total Debt/Mcap(x) | - | - | - | 0.01 | 0.06 |
Compare Financial Ratios of peers of INDRAPRASTHA MEDICAL CORPORATION
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDRAPRASTHA MEDICAL CORPORATION | ₹2,128.8 Cr | 1.3% | -12.3% | 124.7% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹88,715.9 Cr | 3.4% | -6.6% | 49% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹75,026.8 Cr | 5.7% | -8.7% | 59.1% | Stock Analytics | |
| GLOBAL HEALTH | ₹37,656.8 Cr | 6.7% | -13.1% | 164.4% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹32,512.3 Cr | 2.6% | -6.4% | 59.4% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹25,374.5 Cr | 2% | -9.6% | 59.5% | Stock Analytics | |
INDRAPRASTHA MEDICAL CORPORATION Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDRAPRASTHA MEDICAL CORPORATION | 1.3% |
-12.3% |
124.7% |
| SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses
